Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancer
2008

Using MRI to Plan Breast-Conserving Surgery

Sample size: 32 publication Evidence: moderate

Author Information

Author(s): Bhattacharyya M, Ryan D, Carpenter R, Vinnicombe S, Gallagher C J

Primary Institution: St Bartholomew's Hospital

Hypothesis

Can MRI improve the planning of breast-conserving surgery after neoadjuvant chemotherapy for early breast cancer?

Conclusion

MRI is superior to conventional methods for assessing the response to chemotherapy and helps in planning breast-conserving surgery.

Supporting Evidence

  • Magnetic resonance imaging had 87.5% sensitivity and 50% specificity for detecting residual invasive cancer.
  • 84% of patients were identified as suitable for breast-conserving surgery after chemotherapy.
  • 90.5% of those who chose breast-conserving surgery achieved it.

Takeaway

Doctors used MRI to see how well chemotherapy worked for breast cancer, and it helped many women keep their breasts instead of needing surgery.

Methodology

Patients with invasive breast cancer were recruited to undergo MRI, mammography, and ultrasound before and after chemotherapy to assess tumor response.

Potential Biases

Potential bias in patient selection and the influence of MRI results on surgical decisions.

Limitations

The study did not assess the impact of MRI on the decision-making process for surgery.

Participant Demographics

Patients aged 24 to 60, with a median age of 42; 69% pre-menopausal and 31% peri- or post-menopausal.

Statistical Information

P-Value

p<0.05

Confidence Interval

95% CI=68–97%

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6604171

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication